American Lung Association honors UCLA cancer researcher

Steven M. Dubinett, MD
Steven M. Dubinett

The American Lung Association honored Steven M. Dubinett, MD, during its Lung Force Gala in Los Angeles for his contributions to lung cancer research and treatment.

The association recognized Dubinett for helping to advance academic, clinical and community partnerships designed to accelerate scientific discoveries and clinical breakthroughs that benefit the health of people around the world.

Dubinett is professor of medicine, pathology and laboratory medicine, and professor of molecular and medical pharmacology at David Geffen School of Medicine at UCLA. He also is chief of pulmonary, critical care, sleep medicine, clinical immunology and allergy at UCLA, as well as associate vice chancellor and senior associate dean for translational research.

“It is such an honor to be recognized by an organization who has supported my research since day one,” Dubinett said in a press release. “This honor isn’t just about me, but highlights the work of our laboratory members and our collaborators for their critical insights and exceptional creativity, which are leading to translational discoveries for patients with lung cancer.”

Dubinett joined UCLA in 1988. His early research focused on why individuals with lung cancer were not responding to immunotherapy. Today, his research explores the role of immunity and inflammation in the development of lung cancer treatment.

Steven M. Dubinett, MD
Steven M. Dubinett

The American Lung Association honored Steven M. Dubinett, MD, during its Lung Force Gala in Los Angeles for his contributions to lung cancer research and treatment.

The association recognized Dubinett for helping to advance academic, clinical and community partnerships designed to accelerate scientific discoveries and clinical breakthroughs that benefit the health of people around the world.

Dubinett is professor of medicine, pathology and laboratory medicine, and professor of molecular and medical pharmacology at David Geffen School of Medicine at UCLA. He also is chief of pulmonary, critical care, sleep medicine, clinical immunology and allergy at UCLA, as well as associate vice chancellor and senior associate dean for translational research.

“It is such an honor to be recognized by an organization who has supported my research since day one,” Dubinett said in a press release. “This honor isn’t just about me, but highlights the work of our laboratory members and our collaborators for their critical insights and exceptional creativity, which are leading to translational discoveries for patients with lung cancer.”

Dubinett joined UCLA in 1988. His early research focused on why individuals with lung cancer were not responding to immunotherapy. Today, his research explores the role of immunity and inflammation in the development of lung cancer treatment.